In a significant development, Myriad Genetics has entered into a partnership with Clairity and MagView to enhance breast cancer risk assessment tools. This collaboration integrates Clairity’s AI ...
Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, ...
Unlike compound bows, spotting scope manufacturers don’t release a new flagship model each year. In fact, many optic companies will go years between developing a new spotter. That’s why, as hunters, ...
Get the latest Myriad Genetics, Inc. (MYGN) stock news and headlines to help you in your trading and investing decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results